BoomerangFX
PrivateLast Round
Series A
Mar 15, 2022
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BoomerangFX is a healthcare SaaS company that provides an AI-powered, all-in-one practice management and marketing automation platform for aesthetic, cosmetic surgery, and specialty private-pay healthcare practices.
Sector
Enterprise Software
Verticals
Vertical SaaS, EHR & EMR, Marketing, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BoomerangFX Comparables
Compare BoomerangFX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PatientNow | 90% | |
| AestheticsPro | 87% | |
| Prospyr Medical, Inc. | 87% | |
BoomerangFX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 15, 2022 | ||||
| Series B | Mar 15, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2026
Grew 17% QoQ, from 102 to 119 employees.
- May 14, 2026
Monthly visitors increased 83% MoM, reaching 14.7K.
BoomerangFX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BoomerangFX's valuation, stock price, and market status.